Daunorubicin-prednisone treatment of erythroleukemia.
D000293:Adolescent; D000328:Adult; D001856:Bone Marrow Examination; D002228:Carbenicillin / Q000008:administration & dosage / Q000627:therapeutic use; D002512:Cephalothin / Q000008:administration & dosage / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004906:Erythrocyte Count; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D004915:Leukemia, Erythroblastic, Acute / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D012075:Remission, Spontaneous; D013997:Time Factors
D005839:Gentamicins; D002228:Carbenicillin; D002512:Cephalothin; D011241:Prednisone; D003630:Daunorubicin